N
Nikos Donos
Researcher at Queen Mary University of London
Publications - 84
Citations - 4327
Nikos Donos is an academic researcher from Queen Mary University of London. The author has contributed to research in topics: Periodontitis & Population. The author has an hindex of 31, co-authored 81 publications receiving 3504 citations. Previous affiliations of Nikos Donos include University of London & University College London.
Papers
More filters
Journal ArticleDOI
Primary prevention of periodontitis: managing gingivitis
Iain L. C. Chapple,Fridus van der Weijden,Christof Doerfer,David Herrera,Lior Shapira,David Polak,Phoebus N. Madianos,Anna Louropoulou,Eli E. Machtei,Nikos Donos,Henry Greenwell,Ari J. Van Winkelhoff,Bahar Kuru,Nicole B. Arweiler,Wim Teughels,Mario Aimetti,Ana Molina,Eduardo Montero,Filippo Graziani +18 more
TL;DR: Data support the belief that professionally administered plaque control significantly improves gingival inflammation and lowers plaque scores, with some evidence that reinforcement of oral hygiene provides further benefit.
Journal ArticleDOI
Association between overweight/obesity and periodontitis in adults. A systematic review
TL;DR: Results of a systematic review investigating the association between overweight or obesity (as defined by the World Health Organization) and periodontitis are presented.
Journal ArticleDOI
Modified titanium surfaces promote accelerated osteogenic differentiation of mesenchymal stromal cells in vitro
TL;DR: Osteogenic responses to SLActive were moderately better than the hydrophobic SLA surface and gene expression studies indicate that WNT5A activation may be responsible for this increased osteogenic differentiation.
Journal ArticleDOI
Association of the metabolic syndrome with severe periodontitis in a large U.S. population-based survey.
Francesco D'Aiuto,Wael Sabbah,Gopalakrishnan Netuveli,Nikos Donos,Aroon D. Hingorani,John E. Deanfield,Georgios Tsakos +6 more
TL;DR: Severe periodontitis is associated with metabolic syndrome in middle-aged individuals and further studies are required to test whether improvements in oral health lead to reductions in cardiometabolic traits and the risk of metabolic syndrome or vice versa.
Journal ArticleDOI
Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial.
Francesco D'Aiuto,N Gkranias,Devina Bhowruth,Tauseef Khan,Marco Orlandi,Jean Suvan,Stefano Masi,Georgios Tsakos,Steve Hurel,Aroon D. Hingorani,Nikos Donos,John E. Deanfield,Alastair Lomax,Attila Horváth,Riccardo Zambon,Shiefung Tay,Nikos Tatarakis,Dave Spratt,Isabel Kingston,Mohamed Parkar,Ulpee Darbar,Kalpesh Patel,Elaine Giedrys-Leeper,Zoe Harrington,Kevin C.R. Baynes,Francis J. Hughes,David Gable,Pratik Patel,Ankeet Haria,Michael Lessani,Donna Moskal-Fitzpatrick,Maria Chiara Curra,Banbai Hirani,Kasia Niziolek,Tiffany Mellor +34 more
TL;DR: Compared with CPT, IPT reduced HbA1c in patients with type 2 diabetes and moderate-to-severe periodontitis after 12 months, suggesting that routine oral health assessment and treatment ofperiodontitis could be important for effective management of type 2abetes.